CVE-2026-19731: TÜBİTAK BİLGEM Software Technologies Research Institute İmzager · Path Traversal
Affects TÜBİTAK BİLGEM Software Technologies Research Institute İmzagerSource CVE Database V5
Not known to be exploited · CVSS 3.3 Low : upgrade to 2.10.7 when convenient.
Data as of 4 Nov 2026, 08:43 UTC
Thin evidence
One scorer or none| CNA (TR-CERT) | CVSS 3.1 | 3.3 |
|---|
- Patch
- Available – fixed in 2.10.7
CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:N/I:L/A:NExploitation evidence
Disclosed: evidence found.
CVE published 4 Nov 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponized: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 3 Nov 2026.
What to do
Upgrade TÜBİTAK BİLGEM Software Technologies Research Institute İmzager to 2.10.7.
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| TÜBİTAK BİLGEM Software Technologies Research Instituteİmzager | Affected
| Fixed in
|
AI-suggested
Upgrade İmzager to version 2.10.7 or later, where this path traversal vulnerability is fixed. No other mitigation is indicated or necessary.
Description
A path traversal vulnerability (CWE-22) exists in TÜBİTAK BİLGEM Software Technologies Research Institute's İmzager software versions from 2.10.5 up to but not including 2.10.7. This flaw allows unauthorized path traversal, potentially leading to limited integrity impact. The issue is fixed in version 2.10.7.